NASDAQ:GANX | Cash Flow Statement | Gain Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.68M
2026-03-31-$5.61M$21,303.00-$4.73M$404,321.00
2025-12-31-$4.54M$28,241.00-$4.62M$16.55M
2025-09-30-$5.28M
2025-06-30-$5.81M
2025-03-31-$4.53M$20,660.00-$3.82M$2.4M
2024-12-31-$3.77M$21,307.00-$3.45M-$43,447.00$2.31M
2024-09-30-$4.49M
2024-06-30-$8.14M
2024-03-31-$4.01M$20,528.00-$3.59M$3.02M-$145,803.00
2023-12-31-$4.72M$23,589.00-$5.66M$3.14M$9.56M
2023-09-30-$4.72M
2023-06-30-$7.69M
2023-03-31-$5.14M$19,242.00-$4.22M$2.11M$748,908.00
2022-12-31-$4.67M$18,110.00-$3.9M$133,830.00-$21,582.00
2022-09-30-$4.56M
2022-06-30-$5.09M
2022-03-31-$3.27M$8,209.00-$2.45M$7,825.00-$7,825.00-$37,974.00
2021-12-31-$3.22M$5,788.00-$4.15M$11,098.00-$11,098.00-$9,735.00
2021-09-30-$4.66M
2021-06-30-$3.56M
2021-03-31-$2.45M$3,403.00-$2.81M$28,488.00-$28,488.00$41.99M
2020-12-31-$1.66M$2,834.00-$1.31M$14,551.00-$14,551.00-$440,347.00
2020-09-30-$794,371.00
2020-06-30-$543,362.00
2020-03-31-$584,268.00$2,101.00-$752,816.00$4,897.00-$4,897.00$1.39M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$20.16M$94,046.00-$18.47M$28.45M
2024-12-31-$20.41M$84,071.00-$18.87M$4.98M$13.01M
2023-12-31-$22.27M$83,579.00-$18.87M$10.22M$12.64M
2022-12-31-$17.59M$64,168.00-$14.69M-$14.77M-$78,774.00
2021-12-31-$13.89M$15,484.00-$12.37M$94,212.00-$94,212.00$41.77M
2020-12-31-$3.58M$9,592.00-$3.24M$20,826.00-$20,826.00$10.49M